Cibus CBUS 深 沪
等待开盘 12-19 09:30:00 美东时间
1.56
+0.020
+1.30%
华盛通- 最 高1.6192
- 今 开1.56
- 成交量 14.11万股
- 最 低 1.53
- 昨 收 1.54
- 总市值 8196.32万
- 52周最高 3.40
- 市盈率 静 --
- 换手率 0.27%
- 52周最低 1.09
- 委 比 -71.43%
- 总股本 5254.05万
- 历史最高 1594.50
- 量 比 1.08
- 振 幅 5.79%
- 历史最低 1.09
- 每 手 1
- 风险率 0.55%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cibus Welcomes EU Agreement On New Genomic Techniques Framework Following Call For Action From Agri‑Food Organizations
Political agreement on New Genomic Techniques (NGTs), including gene editing, advances a science-based path for plant breeding innovation and supports Cibus' plans to bring improved traits to European growersThe agreed
12-11 20:10
Cibus shares are trading lower after the company reported worse-than-expected Q3 sales results.
Cibus shares are trading lower after the company reported worse-than-expected Q...
11-14 05:17
Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
11-13 19:11
Cibus Announces the Election of Craig Wichner to Board of Directors
Cibus, Inc. announced the election of Craig Wichner to its Board of Directors and Strategy Committee. Wichner, a leader in farmland investment and sustainable agriculture, brings expertise in financial strategy and industry insight. His experience in regenerative farming and agricultural innovation aligns with Cibus' goal to drive sustainable crop development. Wichner’s加入 bolstering Cibus’ position in the agricultural market and aiding in creatin...
11-11 12:00
Cibus to Report Third Quarter 2025 Financial Results on November 13, 2025 After the Market Close and Host Conference Call
Cibus, Inc. will release its third quarter 2025 financial results on November 13, 2025, followed by a conference call and audio webcast at 4:30 p.m. ET. Participants can join via +1-800-274-8461 (U.S.) or +1-203-518-9814 (International) using the conference ID "CIBUS" or 24287. A replay will be available until November 27, 2025, and an audio webcast with slides will be accessible on investor.cibus.com. Cibus, a leader in gene-edited traits for cr...
10-30 20:05
Cibus Agrees With AgVayā To Develop Strategies And Solutions For Indian Agriculture Market
Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced its agreement with AgVayā, a strategic growth advisory firm
10-16 19:57
Cibus and AgVayā Collaborate to Introduce Indian Rice Growers to New Solutions to Scale Crop Productivity Through Advanced Gene Editing
Cibus and AgVayā collaborate to accelerate gene editing technology adoption in India's rice industry, aiming to develop resilient and productive rice varieties for sustainable agriculture. This partnership focuses on addressing key challenges, fostering collaborations, and integrating advanced traits to enhance rice production and contribute to global food security.
10-16 11:46
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Genprex (NASDAQ:GNPX) stock increased by 46.4% to $0.37 during Tuesday...
10-15 05:06
Cibus Completes Field Testing For Second-Generation Herbicide Tolerance Edited Canola With Positive Results
Field testing confirms efficacy of HT2 trait in Canola under real-world conditionsHT2 trait will be offered to potential seed licensing partners for introduction into commercial Canola seed productsSAN DIEGO, Oct. 02,
10-02 19:08
Cibus Announces Positive Field Trial Results for Second-Generation Herbicide Tolerance (HT2) Edited Canola
Cibus Inc. has successfully completed field testing for its second-generation herbicide tolerance (HT2) edited Canola, achieving positive results. The HT2 trait demonstrates improved weed management with fewer herbicide applications and can be "stacked" with other traits for greater flexibility. This advancement highlights Cibus' Rapid Trait Development System (RTDS), which accelerates trait development compared to traditional methods. The compan...
10-02 11:00
